StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
GENESYS.BO$267.60+3.48%
Fair $267.60+0.0%

GENESYS.BO

Genesys International Corporation Limited

Technology / Software - ApplicationBSE

$267.60

+9.00 (+3.48%)

Fairly Valued+0.0%Fair Value $267.60Fund rank 26/100 · Data gapFallback financials|
SA 56/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-1.1B · quality 56.7/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 14/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

56/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · GENESYS.BOLocal privado en este navegador · Genesys International Corporation Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$11.2B

P/E

18.4x

↓

EV/EBITDA

8.1x

↓

ROE

10.1%

↑

Gross Margin

56.9%

↑

Debt/Equity

0.22

↑
52-Week Range$268
$199$757

TradingView lightweight chart

GENESYS.BO price, volumen y niveles de valoración

Último $267.60Periodo +1882.2%
Fair value: $267.60

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+38.7%

FCF CAGR

—

FCF margin

-34.4%

FCF / Net income

-1.90x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.11B · net income $562.2M · FCF $-1.07B

2022-FY → 2025-FY

Gross margin

56.9%+26.2% pts

Operating margin

29.3%+21.3% pts

Net margin

18.1%+6.6% pts

FCF margin

-34.4%-30.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3.11B$3.11B$1.98B$1.81B$1.17B
Net Income$562.2M$562.2M$220.7M$190.8M$134.1M
EBITDA$1.46B$1.46B$855.7M$651.9M$-142.7M
EPS14.0614.065.745.294.13
Gross Margin56.9%56.9%53.8%47.0%30.8%
Operating Margin29.3%29.3%19.7%11.9%7.9%
Net Margin18.1%18.1%11.1%10.5%11.5%
Balance Sheet
Debt/Equity0.220.220.120.100.13
Current Ratio2.852.85———
Cash Flow
Free Cash Flow$-1.07B$-1.07B$-645.8M$-1.33B$-50.2M
Returns
ROE10.1%10.1%4.5%4.7%6.5%
Valuation
P/E18.3918.39124.6664.00145.81
EV/EBITDA8.128.1232.5719.20—
P/B1.931.935.623.029.91
Growth & Yield
Revenue Growth56.9%56.9%9.4%55.5%—
EPS Growth144.9%144.9%8.5%28.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

19.1%

exigente

EPS terminal req.

$23.75

Spread vs growth

125.9%

5Y implied EPS CAGR

15.4%

exigente

EPS terminal req.

$28.73

Spread vs growth

129.6%

10Y implied EPS CAGR

12.7%

razonable

EPS terminal req.

$46.27

Spread vs growth

132.3%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -63.2%

Total return

-63.2%

Start / end P/E

126.8x → 19.0x

EPS bridge

5.74 → 14.06

Residual

-123.2%

EPS growth+144.9%
Multiple rerating-85.0%
Dividend+0.0%
Residual / FX / buybacks / cross-term-123.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.